Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC labeling

This article was originally published in The Tan Sheet

Executive Summary

Generic labeling mock-ups for cimetidine 200 mg tablets, loperamide HCl (1 mg oral solution and 2 mg chewable tablets) and acetaminophen suppositories (120 mg, 325 mg and 650 mg) posted on FDA's OTC Web site (www.fda.gov/cder/otc). Reference labels are second wave published by agency to enable private labelers to implement OTC labeling final rule before reference listed drug holders change their labeling. First set of mock-ups was released in February; naproxen sodium tablets and miconazole vaginal cream labeling expected soon (1"The Tan Sheet" Feb. 26, p. 4)
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS092350

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel